Latest Breaking News On - Doctor about - Page 7 : vimarsana.com

Shutterstock (2) A medication approved to treat type 2 diabetes may help people with obesity lose 10 to 15 percent of their body weight an amount that healthcare professionals say could help reduce the risk for serious chronic illnesses. Semaglutide, sold under the brand names Ozempic and Rybelsus, helped most people with obesity in a clinical trial lose at least 10 percent of their body weight, and more than half of them reduced their weight by at least 15 percent, according to the study results, which were published in February 2021 in the The study focused on a once-weekly injection of semaglutide at a higher dose than is approved for treatment of type 2 diabetes. The drug’s manufacturer, Novo Nordisk, is now seeking approval from the U.S. Food and Drug Administration (FDA) to sell a weekly injected version of the medication as a weight loss aid.

United statesBaton rougeFrank greenwayBeverly tchangRobert kushnerPennington biomedical research centerDrug administrationNorthwestern university feinberg school of medicineNovo nordiskNew england journalNorthwestern university feinberg schoolConnection betweenMay complementHealthy lifestyleIncrease weightDoctor about